Role Summary
Senior Director, Clinical Development to lead clinical strategy and execution for the companyβs ADC and radioligand therapy portfolio across all development stages.
Responsibilities
- Lead and execute the clinical development strategy for novel oncology therapies.
- Collaborate with internal and external stakeholders to design and implement a clinical development plan across indications.
- Author/lead key clinical trial documents and clinical sections of regulatory filings such as pre-INDs and INDs.
- Serve as the primary Medical Monitor for assigned programs, including overseeing internal and external teams and providing medical guidance to CRO partners and clinical sites.
- Support safety monitoring and pharmacovigilance activities.
- Collaborate cross-functionally with clinical operations, regulatory, project management, manufacturing, and business development to define timelines, manage risks, and ensure milestone delivery.
- Work closely with translational sciences to integrate key biomarker and pharmacodynamic endpoints into clinical study designs.
- Establish and maintain strong relationships with PIs, KOLs and other external stakeholders.
- Review, assess, interpret, and communicate clinical trial data to internal stakeholders and external partners.
- Lead clinical trial data publication efforts.
- Facilitate key meetings such as advisory boards, safety review committees, investigator meetings.
Qualifications
- Required: M.D., D.O. or equivalent.
- Preferred: Board certification in medical oncology or hematology.
- Required: A minimum of 2-4+ years of experience leading Clinical Development and Phase 1β3 oncology clinical trials in a biotech or pharmaceutical setting.
Skills
- Proven experience advancing therapeutic programs from IND-enabling studies through early and late-stage clinical development.
- Understanding of FDA and EMA regulatory requirements and successful track record in regulatory interactions.
- Demonstrated leadership and ability to effectively manage cross-functional teams.